• The RayPilot solution

    Enables Hypofractionated Accurate RadioTherapy (HART)

Home / Healthcare professionals

RayPilot offers accurate localization and tracking of prostate motion

Micropos Medical provide advanced technologies, powered by Artificial Intelligence (AI),  with potential to enhance the accuracy in radiotherapy of cancer. RayPilot HypoCath, including a patented temporary transmitter, tracks the prostate tumor movements and outlines urethra  in real time in 3D. This can facilitate hypofractionated radiation therapy when physicians reduce treatment margins to a minimum (sparing healthy tissue) while increasing the dose to the tumor (less number of fractions), for a more efficient outcome. All in all to optimize the treatment.


Micropos inleder företrädesemission torsdag den 1 juli

micropos_emissionsmemorandum_210622_low-res anmalningssedel-uf anmalningssedel-uf

Read more

Micropos Medical AB uppdaterar finansiell kalender för 2021 och 2022

Micropos Medical AB (publ), uppdaterar den finansiella kalendern för 2021 och meddelar datum för första kvartalets delårsrapport 2022: Nytt datum 31 augusti 2021 – Delårsrapport kv2…

Read more
See all news


Event calendar 2021

Events taking place during Covid-19 times During 2020 was more or less all planned events canceled as physical meetings. Instead nearly all organisations arranged  Digital…

Read more
See all upcoming events